Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin’s lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system.
This report contains market size and forecasts of Medical Asparaginase in global, including the following market information:
Global Medical Asparaginase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medical Asparaginase Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Medical Asparaginase companies in 2021 (%)
The global Medical Asparaginase market was valued at 415.7 million in 2021 and is projected to reach US$ 456.3 million by 2028, at a CAGR of 1.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Escherichia coli Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Asparaginase include Jazz Pharmaceuticals, Takeda, Medac GmbH, Kyowa Hakko Kirin, Qianhong Bio-pharma, Taj Pharmaceuticals, Mingxing Pharma, Exova and United Biotech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Asparaginase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Asparaginase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Asparaginase Market Segment Percentages, by Type, 2021 (%)
Escherichia coli
Erwinia Chrysanthemi
Pegylated
Global Medical Asparaginase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Asparaginase Market Segment Percentages, by Application, 2021 (%)
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other
Global Medical Asparaginase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Asparaginase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Asparaginase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Medical Asparaginase revenues share in global market, 2021 (%)
Key companies Medical Asparaginase sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Medical Asparaginase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jazz Pharmaceuticals
Takeda
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
Exova
United Biotech

LEAVE A REPLY

Please enter your comment!
Please enter your name here